BH3-only molecule Bim mediates β-cell death in IRS2 deficiency

Area of Science:

• Cell Biology
• Endocrinology
• Molecular Biology

Background:

• Insulin receptor substrate 2 (IRS2) deficiency impairs pancreatic islet function, leading to type 2 diabetes.
• Compensatory beta-cell hyperplasia fails in IRS2-deficient models, contributing to reduced beta-cell mass.

Purpose of the Study:

• To elucidate the molecular mechanisms underlying beta-cell dysfunction and apoptosis in IRS2 deficiency.
• To investigate the role of the BH3-only molecule Bim in IRS2-deficient diabetes.

Main Methods:

• Knockdown of Irs2 gene expression in mouse MIN6 insulinoma cells.
• Analysis of apoptotic cell death, Bim expression, and Forkhead box protein 1 (FoxO1) in response to IRS2 suppression.
• In vivo studies using Irs2-deficient mice with Bim ablation.

Main Results:

• IRS2 suppression induced beta-cell apoptosis, correlating with increased Bim expression.
• Bim knockdown mitigated IRS2 suppression-induced beta-cell death.
• Bim ablation in Irs2-deficient mice restored beta-cell mass, reduced apoptosis, and normalized glucose tolerance.
• FoxO1 mediated Bim upregulation; FoxO1 knockdown partially reduced beta-cell death.

Conclusions:

• Bim is a key mediator of beta-cell apoptosis and mass reduction in IRS2-deficient diabetes.
• Targeting Bim may offer a therapeutic strategy for IRS2-related diabetes.